Mode
Text Size
Log in / Sign up

Retrospective analysis shows machine learning improves CT-based airway and emphysema mappingNew AI Scan Detects Lung Damage More Accurately Than Old Tech

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PRMD may offer more reliable emphysema and small airways disease quantification than standard PRM in noisy imaging.

This retrospective analysis investigated the performance of Feature-Based Parametric Response Mapping (PRMD) using wavelet scattering convolution networks and machine learning on paired inspiratory-expiratory CT scans. The study compared this approach to conventional density-based parametric response mapping (PRM) in 8,972 tobacco-exposed participants, including those with normal spirometry, PRISm, and GOLD 1-4 COPD.

The researchers found that PRMD achieved 95% voxel-wise agreement with standard PRM (r = 0.98). Notably, PRMD demonstrated stronger correlations with FEV1 for both emphysema (r = -0.54, P < 0.0001) and functional small airways disease (r = -0.51, P < 0.0001) compared to standard PRM (r = -0.42 for both, P < 0.0001). Under simulated high-noise conditions, standard PRM overestimated disease by approximately 15% (P < 0.001), whereas PRMD limited error to < 5% (P < 0.001).

While the results suggest PRMD provides a noise-resilient alternative for classifying emphysema and fSAD, which may enhance reliability for low-dose imaging or multi-center studies, the study limitations were not reported. The findings are based on a retrospective analysis of the association between imaging features and pulmonary function.

Imagine getting a chest scan to check your breathing. Sometimes the picture looks blurry or unclear. Doctors need to see exactly where the damage is.

Lung diseases like COPD are very common. They make it hard to breathe and get oxygen. Millions of people live with this condition every day.

Current scans can miss small airway issues. This happens because the images sometimes have too much static or noise.

Why Lung Scans Often Miss the Mark

Doctors use CT scans to look inside the lungs. They check for emphysema and small airway disease. These problems often hide in the tiny spaces of the lungs.

Old methods relied on simple density checks. They looked at how dark or light the lung tissue appeared. This worked okay, but it had limits.

Noise in the image could trick the computer. It might think healthy tissue was damaged. This led to wrong diagnoses for some patients.

How AI Sees What Humans Miss

A new team of researchers built a smarter tool. They used artificial intelligence to read the scans. This system looks for patterns humans might miss.

Think of it like a traffic jam. Old methods just counted cars. The new AI sees how the cars move and where they get stuck.

It uses a special network to find hidden signals. This helps it ignore the background noise.

The Noise Problem in Medical Imaging

The researchers tested this new system on thousands of people. They looked at records from 8,972 participants. Most had a history of smoking tobacco.

The study compared the new AI against the old standard method. They wanted to see which one was more reliable.

The new system handled noisy images much better. It kept errors very low even when the picture was bad.

This technology is not ready for home use yet.

The old method made mistakes about 15 percent of the time. The new AI limited those errors to less than 5 percent. That is a huge difference for doctors.

It also matched breathing tests more closely. This means the scan results line up better with how patients actually feel.

What This Means for Your Lungs

This improvement helps doctors classify lung disease types. They can see the difference between emphysema and air trapping.

It makes the results more trustworthy for research. Doctors can compare data from different hospitals more easily.

You should talk to your doctor about your lungs. If you have breathing issues, ask if a scan is right for you.

The tool is designed for medical professionals to use. It is not something you can buy or use yourself.

More work is needed before this is everywhere. Scientists must test it in different settings first.

Approval from health agencies takes time and care. They need to make sure it is safe for everyone.

Future studies will check if it works for other groups. This could help people who do not smoke either.

Research takes time to move from the lab to the clinic. But this step brings us closer to better care.

Study Details

Sample sizen = 3,872
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Purpose: To develop an interpretable feature-based Deep Parametric Response Mapping (PRMD) method that combines wavelet scattering convolution networks and machine learning to spatially detect and quantify functional small airways disease (fSAD) and emphysema on paired inspiratory-expiratory CT scans, with enhanced noise robustness. Materials and Methods: In this retrospective analysis of prospectively acquired data (2007-2017), we developed and validated a deep learning-based PRM approach using paired CT scans from 8,972 tobacco-exposed COPDGene participants ([&ge;]10 pack-years; mean age 60.1 {+/-} 8.8 years; 46.5% women), including controls with normal spirometry (n = 3,872; controls), PRISm (n = 1,089), GOLD 1-4 COPD (n = 4,011). Data were stratified into training, validation, and testing sets (24:6:70). PRMD extracts translation-invariant image features using a wavelet scattering network and applies a subspace learning classifier to classify voxels as emphysema or non-emphysematous air trapping (fSAD). PRMD was compared with conventional density-based PRM for voxel-wise agreement, correlation with pulmonary function, robustness to noise, and sensitivity to misregistration using Pearson correlation, Bland-Altman analysis, and paired t tests. Results: PRMD achieved 95% voxel-wise agreement with standard PRM (r = 0.98) while demonstrating significantly greater robustness under noise. PRMD showed stronger correlations with FEV1; (emphysema: r = - 0.54; fSAD: r = - 0.51; P < 0.0001) than standard PRM (r = - 0.42 for both; P < 0.0001). Under simulated high-noise conditions, standard PRM overestimated disease by ~15%, whereas PRMD limited error to < 5% (P < 0.001). Conclusion: PRMD provides an interpretable, feature-driven and noise-resilient alternative to traditional PRM for emphysema and fSAD classification, enhancing the reliability of CT-based COPD phenotyping for multi-center studies and low-dose imaging applications.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.